University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 11 of 16
Self-Directed Biological Transformation Initiative
NCT02241226
Physical Activity and Education Program for Somali Women
NCT02254902
Continuous Adductor Canal Nerve Blocks: Relative Effects of a Basal Infusion v. Hourly Bolus Doses
NCT02219438
ZIPS Study - Zip Incision aPproximation vs. Suture
NCT02213510
Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss
NCT02141555
Physical Activity and Neuropsychological Outcomes in a Cancer Population
NCT02332876
Improving Negative Symptoms of Psychosis In Real-world Environments
NCT02170051
Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.
NCT02634684
Global Positioning System (GPS) Exposure to Environments & Relations With Biomarkers of Cancer Risk
NCT02094170
The Neurobiology of Approach Avoidance Training in Depression
NCT02330744
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697
Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer
NCT02454140
A Complex Contraception Registry
NCT02219269
Promoting Child Inhibitory Control Skills Around Food
NCT02077387
Predictors of Exposure Success in Public Speaking Anxiety
NCT02163148
Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)
NCT02145247
Researching Effective Sleep Treatments (Project REST)
NCT02120989
Prepackaged Foods to Promote Weight Loss
NCT02136290
Metabolomic Profiling in Adolescents With Obesity and Diabetes
NCT02145572
Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes
NCT02330627
iPad as a Distraction Tool During Facial Laceration Repair
NCT02217436
EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection
NCT02689518
Reproductive Health Survivorship Care Plan Pilot
NCT02176083
Sentinel Lymph Node Mapping Post-Injection Site Pain
NCT02065232
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
NCT02111980
Effects of Methylphenidate (Ritalin®) on the Neural Basis of Anxiety
NCT02021214
Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity
NCT02486042
Pre-exposure Prophylaxis Accessibility Research and Evaluation 2
NCT02125773
Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease
NCT01963845
Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)
NCT02068040
Family Based Treatment for Weight Loss With Breakfast Prescription
NCT02467036
Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma
NCT02043587
Treating Phantom Limb Pain Using Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study
NCT01824082
Nonsmokers Helping Smokers Quit
NCT02010697
Analysis of the Effect of Antimicrobial Soap on Bacterial Survival
NCT02012348
Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response
NCT02495883
Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis
NCT01960257
CCTG 594: Engagement and Retention in Care for HIV+
NCT01957748
Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness
NCT02035202
Care4Today v2.0 Application for Improving Adherence to HIV Medications
NCT02001064
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
NCT01958073
Negative-Positive Valence Domains in Anxiety and Depression
NCT03310398
Effects of Surfactants on the Innate Immune System
NCT01951352
Effect of Surfactants on the Skin Microbiome
NCT01951391
Evaluating Trauma-Informed, Evidence-Informed Interventions for Latino Families Experiencing Domestic Violence
NCT03041558
Optimizing Sedentary Behavior Interventions to Affect Acute Physiological Changes
NCT02544867
An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema
NCT01933464
Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris
NCT01929057
CCTG 593: Testing and Linkage to Care
NCT01941121
Treating Prediabetes in the First Trimester
NCT01926457
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.